nodes	percent_of_prediction	percent_of_DWPC	metapath
Carglumic Acid—CPS1—embryo—testicular cancer	0.155	0.325	CbGeAlD
Carglumic Acid—CPS1—gonad—testicular cancer	0.105	0.221	CbGeAlD
Carglumic Acid—CPS1—female gonad—testicular cancer	0.0854	0.179	CbGeAlD
Carglumic Acid—CPS1—testis—testicular cancer	0.0757	0.159	CbGeAlD
Carglumic Acid—CPS1—lymph node—testicular cancer	0.0549	0.115	CbGeAlD
Carglumic Acid—CPS1—Podofilox—Etoposide—testicular cancer	0.0544	1	CbGdCrCtD
Carglumic Acid—Glutathione—HPGDS—testicular cancer	0.0333	1	CrCbGaD
Carglumic Acid—Infection—Carboplatin—testicular cancer	0.00807	0.0185	CcSEcCtD
Carglumic Acid—Pneumonia—Chlorambucil—testicular cancer	0.00659	0.0151	CcSEcCtD
Carglumic Acid—Body temperature increased—Carboplatin—testicular cancer	0.00642	0.0147	CcSEcCtD
Carglumic Acid—Transaminases increased—Epirubicin—testicular cancer	0.00564	0.0129	CcSEcCtD
Carglumic Acid—Transaminases increased—Doxorubicin—testicular cancer	0.00522	0.012	CcSEcCtD
Carglumic Acid—Weight decreased—Bleomycin—testicular cancer	0.00515	0.0118	CcSEcCtD
Carglumic Acid—Pneumonia—Bleomycin—testicular cancer	0.0051	0.0117	CcSEcCtD
Carglumic Acid—Pneumonia—Dactinomycin—testicular cancer	0.00476	0.0109	CcSEcCtD
Carglumic Acid—Anaemia—Chlorambucil—testicular cancer	0.00473	0.0108	CcSEcCtD
Carglumic Acid—Pneumonia—Ifosfamide—testicular cancer	0.00436	0.00999	CcSEcCtD
Carglumic Acid—Anaemia—Vinblastine—testicular cancer	0.00434	0.00994	CcSEcCtD
Carglumic Acid—Nasopharyngitis—Cisplatin—testicular cancer	0.00434	0.00993	CcSEcCtD
Carglumic Acid—Infestation NOS—Ifosfamide—testicular cancer	0.00433	0.00993	CcSEcCtD
Carglumic Acid—Infestation—Ifosfamide—testicular cancer	0.00433	0.00993	CcSEcCtD
Carglumic Acid—Infection—Chlorambucil—testicular cancer	0.00415	0.00951	CcSEcCtD
Carglumic Acid—Sweating increased—Cisplatin—testicular cancer	0.00408	0.00935	CcSEcCtD
Carglumic Acid—Anorexia—Chlorambucil—testicular cancer	0.00398	0.00913	CcSEcCtD
Carglumic Acid—Bradycardia—Ifosfamide—testicular cancer	0.00396	0.00908	CcSEcCtD
Carglumic Acid—Sweating increased—Etoposide—testicular cancer	0.00374	0.00857	CcSEcCtD
Carglumic Acid—Anaemia—Bleomycin—testicular cancer	0.00366	0.00839	CcSEcCtD
Carglumic Acid—Anorexia—Vinblastine—testicular cancer	0.00365	0.00836	CcSEcCtD
Carglumic Acid—Decreased appetite—Chlorambucil—testicular cancer	0.00363	0.00832	CcSEcCtD
Carglumic Acid—Cardiac disorder—Ifosfamide—testicular cancer	0.00361	0.00827	CcSEcCtD
Carglumic Acid—Gastrointestinal disorder—Chlorambucil—testicular cancer	0.00361	0.00827	CcSEcCtD
Carglumic Acid—Pneumonia—Etoposide—testicular cancer	0.00344	0.00789	CcSEcCtD
Carglumic Acid—Infestation NOS—Etoposide—testicular cancer	0.00342	0.00784	CcSEcCtD
Carglumic Acid—Infestation—Etoposide—testicular cancer	0.00342	0.00784	CcSEcCtD
Carglumic Acid—Gastrointestinal pain—Chlorambucil—testicular cancer	0.00342	0.00783	CcSEcCtD
Carglumic Acid—Anaemia—Dactinomycin—testicular cancer	0.00342	0.00783	CcSEcCtD
Carglumic Acid—Bradycardia—Cisplatin—testicular cancer	0.00341	0.00782	CcSEcCtD
Carglumic Acid—Malnutrition—Ifosfamide—testicular cancer	0.00339	0.00776	CcSEcCtD
Carglumic Acid—Decreased appetite—Vinblastine—testicular cancer	0.00333	0.00763	CcSEcCtD
Carglumic Acid—Abdominal pain—Chlorambucil—testicular cancer	0.0033	0.00757	CcSEcCtD
Carglumic Acid—Body temperature increased—Chlorambucil—testicular cancer	0.0033	0.00757	CcSEcCtD
Carglumic Acid—Infection—Bleomycin—testicular cancer	0.00321	0.00736	CcSEcCtD
Carglumic Acid—Gastrointestinal pain—Vinblastine—testicular cancer	0.00313	0.00717	CcSEcCtD
Carglumic Acid—Anaemia—Ifosfamide—testicular cancer	0.00313	0.00717	CcSEcCtD
Carglumic Acid—Cardiac disorder—Cisplatin—testicular cancer	0.00311	0.00713	CcSEcCtD
Carglumic Acid—Anorexia—Bleomycin—testicular cancer	0.00308	0.00706	CcSEcCtD
Carglumic Acid—Abdominal pain—Vinblastine—testicular cancer	0.00303	0.00694	CcSEcCtD
Carglumic Acid—Asthenia—Chlorambucil—testicular cancer	0.003	0.00687	CcSEcCtD
Carglumic Acid—Infection—Dactinomycin—testicular cancer	0.003	0.00687	CcSEcCtD
Carglumic Acid—Malnutrition—Cisplatin—testicular cancer	0.00292	0.00669	CcSEcCtD
Carglumic Acid—Anorexia—Dactinomycin—testicular cancer	0.00288	0.00659	CcSEcCtD
Carglumic Acid—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—testicular cancer	0.00286	0.00656	CcSEcCtD
Carglumic Acid—Diarrhoea—Chlorambucil—testicular cancer	0.00286	0.00655	CcSEcCtD
Carglumic Acid—Cardiac disorder—Etoposide—testicular cancer	0.00285	0.00653	CcSEcCtD
Carglumic Acid—Decreased appetite—Bleomycin—testicular cancer	0.00281	0.00644	CcSEcCtD
Carglumic Acid—Asthenia—Vinblastine—testicular cancer	0.00275	0.0063	CcSEcCtD
Carglumic Acid—Infection—Ifosfamide—testicular cancer	0.00275	0.00629	CcSEcCtD
Carglumic Acid—Nervous system disorder—Ifosfamide—testicular cancer	0.00271	0.00621	CcSEcCtD
Carglumic Acid—Anaemia—Cisplatin—testicular cancer	0.0027	0.00618	CcSEcCtD
Carglumic Acid—Skin disorder—Ifosfamide—testicular cancer	0.00268	0.00615	CcSEcCtD
Carglumic Acid—Hyperhidrosis—Ifosfamide—testicular cancer	0.00267	0.00612	CcSEcCtD
Carglumic Acid—Vomiting—Chlorambucil—testicular cancer	0.00266	0.00609	CcSEcCtD
Carglumic Acid—Anorexia—Ifosfamide—testicular cancer	0.00263	0.00604	CcSEcCtD
Carglumic Acid—Decreased appetite—Dactinomycin—testicular cancer	0.00262	0.00601	CcSEcCtD
Carglumic Acid—Diarrhoea—Vinblastine—testicular cancer	0.00262	0.006	CcSEcCtD
Carglumic Acid—Dysgeusia—Etoposide—testicular cancer	0.00262	0.006	CcSEcCtD
Carglumic Acid—Body temperature increased—Bleomycin—testicular cancer	0.00256	0.00586	CcSEcCtD
Carglumic Acid—Anaemia—Etoposide—testicular cancer	0.00247	0.00566	CcSEcCtD
Carglumic Acid—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	0.00247	0.00566	CcSEcCtD
Carglumic Acid—Gastrointestinal pain—Dactinomycin—testicular cancer	0.00247	0.00565	CcSEcCtD
Carglumic Acid—Somnolence—Ifosfamide—testicular cancer	0.00246	0.00563	CcSEcCtD
Carglumic Acid—Vomiting—Vinblastine—testicular cancer	0.00243	0.00558	CcSEcCtD
Carglumic Acid—Decreased appetite—Ifosfamide—testicular cancer	0.0024	0.00551	CcSEcCtD
Carglumic Acid—Headache—Vinblastine—testicular cancer	0.0024	0.0055	CcSEcCtD
Carglumic Acid—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.00239	0.00547	CcSEcCtD
Carglumic Acid—Abdominal pain—Dactinomycin—testicular cancer	0.00238	0.00546	CcSEcCtD
Carglumic Acid—Body temperature increased—Dactinomycin—testicular cancer	0.00238	0.00546	CcSEcCtD
Carglumic Acid—Infection—Cisplatin—testicular cancer	0.00237	0.00542	CcSEcCtD
Carglumic Acid—Nervous system disorder—Cisplatin—testicular cancer	0.00234	0.00535	CcSEcCtD
Carglumic Acid—Asthenia—Bleomycin—testicular cancer	0.00232	0.00532	CcSEcCtD
Carglumic Acid—Skin disorder—Cisplatin—testicular cancer	0.00231	0.0053	CcSEcCtD
Carglumic Acid—Hyperhidrosis—Cisplatin—testicular cancer	0.0023	0.00528	CcSEcCtD
Carglumic Acid—Anorexia—Cisplatin—testicular cancer	0.00227	0.0052	CcSEcCtD
Carglumic Acid—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.00226	0.00518	CcSEcCtD
Carglumic Acid—Gastrointestinal pain—Ifosfamide—testicular cancer	0.00226	0.00518	CcSEcCtD
Carglumic Acid—Nasopharyngitis—Epirubicin—testicular cancer	0.00223	0.0051	CcSEcCtD
Carglumic Acid—Abdominal pain—Ifosfamide—testicular cancer	0.00218	0.00501	CcSEcCtD
Carglumic Acid—Body temperature increased—Ifosfamide—testicular cancer	0.00218	0.00501	CcSEcCtD
Carglumic Acid—Infection—Etoposide—testicular cancer	0.00217	0.00497	CcSEcCtD
Carglumic Acid—Asthenia—Dactinomycin—testicular cancer	0.00216	0.00496	CcSEcCtD
Carglumic Acid—Influenza—Epirubicin—testicular cancer	0.00215	0.00493	CcSEcCtD
Carglumic Acid—Skin disorder—Etoposide—testicular cancer	0.00212	0.00486	CcSEcCtD
Carglumic Acid—Hyperhidrosis—Etoposide—testicular cancer	0.00211	0.00484	CcSEcCtD
Carglumic Acid—Anorexia—Etoposide—testicular cancer	0.00208	0.00477	CcSEcCtD
Carglumic Acid—Decreased appetite—Cisplatin—testicular cancer	0.00207	0.00475	CcSEcCtD
Carglumic Acid—Diarrhoea—Dactinomycin—testicular cancer	0.00206	0.00473	CcSEcCtD
Carglumic Acid—Pneumonia—Methotrexate—testicular cancer	0.00206	0.00473	CcSEcCtD
Carglumic Acid—Nasopharyngitis—Doxorubicin—testicular cancer	0.00206	0.00472	CcSEcCtD
Carglumic Acid—Gastrointestinal disorder—Cisplatin—testicular cancer	0.00206	0.00471	CcSEcCtD
Carglumic Acid—Vomiting—Bleomycin—testicular cancer	0.00206	0.00471	CcSEcCtD
Carglumic Acid—Infestation NOS—Methotrexate—testicular cancer	0.00205	0.0047	CcSEcCtD
Carglumic Acid—Infestation—Methotrexate—testicular cancer	0.00205	0.0047	CcSEcCtD
Carglumic Acid—Rash—Bleomycin—testicular cancer	0.00204	0.00467	CcSEcCtD
Carglumic Acid—Dermatitis—Bleomycin—testicular cancer	0.00204	0.00467	CcSEcCtD
Carglumic Acid—Influenza—Doxorubicin—testicular cancer	0.00199	0.00456	CcSEcCtD
Carglumic Acid—Asthenia—Ifosfamide—testicular cancer	0.00198	0.00454	CcSEcCtD
Carglumic Acid—Weight decreased—Epirubicin—testicular cancer	0.00195	0.00446	CcSEcCtD
Carglumic Acid—Somnolence—Etoposide—testicular cancer	0.00194	0.00445	CcSEcCtD
Carglumic Acid—Pneumonia—Epirubicin—testicular cancer	0.00193	0.00442	CcSEcCtD
Carglumic Acid—Infestation NOS—Epirubicin—testicular cancer	0.00192	0.0044	CcSEcCtD
Carglumic Acid—Infestation—Epirubicin—testicular cancer	0.00192	0.0044	CcSEcCtD
Carglumic Acid—Vomiting—Dactinomycin—testicular cancer	0.00192	0.00439	CcSEcCtD
Carglumic Acid—Rash—Dactinomycin—testicular cancer	0.0019	0.00436	CcSEcCtD
Carglumic Acid—Decreased appetite—Etoposide—testicular cancer	0.0019	0.00435	CcSEcCtD
Carglumic Acid—Diarrhoea—Ifosfamide—testicular cancer	0.00189	0.00433	CcSEcCtD
Carglumic Acid—Gastrointestinal disorder—Etoposide—testicular cancer	0.00188	0.00432	CcSEcCtD
Carglumic Acid—Body temperature increased—Cisplatin—testicular cancer	0.00188	0.00432	CcSEcCtD
Carglumic Acid—Weight decreased—Doxorubicin—testicular cancer	0.0018	0.00413	CcSEcCtD
Carglumic Acid—Pneumonia—Doxorubicin—testicular cancer	0.00179	0.00409	CcSEcCtD
Carglumic Acid—Gastrointestinal pain—Etoposide—testicular cancer	0.00179	0.00409	CcSEcCtD
Carglumic Acid—Infestation NOS—Doxorubicin—testicular cancer	0.00178	0.00407	CcSEcCtD
Carglumic Acid—Infestation—Doxorubicin—testicular cancer	0.00178	0.00407	CcSEcCtD
Carglumic Acid—Vomiting—Ifosfamide—testicular cancer	0.00176	0.00403	CcSEcCtD
Carglumic Acid—Bradycardia—Epirubicin—testicular cancer	0.00175	0.00402	CcSEcCtD
Carglumic Acid—Rash—Ifosfamide—testicular cancer	0.00174	0.00399	CcSEcCtD
Carglumic Acid—Dermatitis—Ifosfamide—testicular cancer	0.00174	0.00399	CcSEcCtD
Carglumic Acid—Abdominal pain—Etoposide—testicular cancer	0.00173	0.00395	CcSEcCtD
Carglumic Acid—Body temperature increased—Etoposide—testicular cancer	0.00173	0.00395	CcSEcCtD
Carglumic Acid—Asthenia—Cisplatin—testicular cancer	0.00171	0.00392	CcSEcCtD
Carglumic Acid—Cardiac disorder—Methotrexate—testicular cancer	0.00171	0.00391	CcSEcCtD
Carglumic Acid—Diarrhoea—Cisplatin—testicular cancer	0.00163	0.00374	CcSEcCtD
Carglumic Acid—Bradycardia—Doxorubicin—testicular cancer	0.00162	0.00372	CcSEcCtD
Carglumic Acid—Malnutrition—Methotrexate—testicular cancer	0.0016	0.00367	CcSEcCtD
Carglumic Acid—Cardiac disorder—Epirubicin—testicular cancer	0.0016	0.00366	CcSEcCtD
Carglumic Acid—Dysgeusia—Methotrexate—testicular cancer	0.00157	0.0036	CcSEcCtD
Carglumic Acid—Asthenia—Etoposide—testicular cancer	0.00157	0.00359	CcSEcCtD
Carglumic Acid—Vomiting—Cisplatin—testicular cancer	0.00152	0.00347	CcSEcCtD
Carglumic Acid—Rash—Cisplatin—testicular cancer	0.0015	0.00344	CcSEcCtD
Carglumic Acid—Dermatitis—Cisplatin—testicular cancer	0.0015	0.00344	CcSEcCtD
Carglumic Acid—Malnutrition—Epirubicin—testicular cancer	0.0015	0.00344	CcSEcCtD
Carglumic Acid—Diarrhoea—Etoposide—testicular cancer	0.00149	0.00342	CcSEcCtD
Carglumic Acid—Anaemia—Methotrexate—testicular cancer	0.00148	0.00339	CcSEcCtD
Carglumic Acid—Cardiac disorder—Doxorubicin—testicular cancer	0.00148	0.00339	CcSEcCtD
Carglumic Acid—Dysgeusia—Epirubicin—testicular cancer	0.00147	0.00336	CcSEcCtD
Carglumic Acid—Vomiting—Etoposide—testicular cancer	0.00139	0.00318	CcSEcCtD
Carglumic Acid—Malnutrition—Doxorubicin—testicular cancer	0.00139	0.00318	CcSEcCtD
Carglumic Acid—Anaemia—Epirubicin—testicular cancer	0.00139	0.00318	CcSEcCtD
Carglumic Acid—Rash—Etoposide—testicular cancer	0.00138	0.00315	CcSEcCtD
Carglumic Acid—Dermatitis—Etoposide—testicular cancer	0.00138	0.00315	CcSEcCtD
Carglumic Acid—Headache—Etoposide—testicular cancer	0.00137	0.00313	CcSEcCtD
Carglumic Acid—Dysgeusia—Doxorubicin—testicular cancer	0.00136	0.00311	CcSEcCtD
Carglumic Acid—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.00135	0.0031	CcSEcCtD
Carglumic Acid—Infection—Methotrexate—testicular cancer	0.0013	0.00298	CcSEcCtD
Carglumic Acid—Nervous system disorder—Methotrexate—testicular cancer	0.00128	0.00294	CcSEcCtD
Carglumic Acid—Anaemia—Doxorubicin—testicular cancer	0.00128	0.00294	CcSEcCtD
Carglumic Acid—Skin disorder—Methotrexate—testicular cancer	0.00127	0.00291	CcSEcCtD
Carglumic Acid—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.00127	0.0029	CcSEcCtD
Carglumic Acid—Hyperhidrosis—Methotrexate—testicular cancer	0.00126	0.0029	CcSEcCtD
Carglumic Acid—Anorexia—Methotrexate—testicular cancer	0.00125	0.00286	CcSEcCtD
Carglumic Acid—Infection—Epirubicin—testicular cancer	0.00122	0.00279	CcSEcCtD
Carglumic Acid—Nervous system disorder—Epirubicin—testicular cancer	0.0012	0.00275	CcSEcCtD
Carglumic Acid—Skin disorder—Epirubicin—testicular cancer	0.00119	0.00272	CcSEcCtD
Carglumic Acid—Hyperhidrosis—Epirubicin—testicular cancer	0.00118	0.00271	CcSEcCtD
Carglumic Acid—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.00117	0.00269	CcSEcCtD
Carglumic Acid—Anorexia—Epirubicin—testicular cancer	0.00117	0.00267	CcSEcCtD
Carglumic Acid—Somnolence—Methotrexate—testicular cancer	0.00116	0.00266	CcSEcCtD
Carglumic Acid—Decreased appetite—Methotrexate—testicular cancer	0.00114	0.0026	CcSEcCtD
Carglumic Acid—Gastrointestinal disorder—Methotrexate—testicular cancer	0.00113	0.00259	CcSEcCtD
Carglumic Acid—Infection—Doxorubicin—testicular cancer	0.00112	0.00258	CcSEcCtD
Carglumic Acid—Nervous system disorder—Doxorubicin—testicular cancer	0.00111	0.00254	CcSEcCtD
Carglumic Acid—Skin disorder—Doxorubicin—testicular cancer	0.0011	0.00252	CcSEcCtD
Carglumic Acid—Hyperhidrosis—Doxorubicin—testicular cancer	0.00109	0.00251	CcSEcCtD
Carglumic Acid—Somnolence—Epirubicin—testicular cancer	0.00109	0.00249	CcSEcCtD
Carglumic Acid—Anorexia—Doxorubicin—testicular cancer	0.00108	0.00247	CcSEcCtD
Carglumic Acid—Gastrointestinal pain—Methotrexate—testicular cancer	0.00107	0.00245	CcSEcCtD
Carglumic Acid—Decreased appetite—Epirubicin—testicular cancer	0.00106	0.00244	CcSEcCtD
Carglumic Acid—Gastrointestinal disorder—Epirubicin—testicular cancer	0.00106	0.00242	CcSEcCtD
Carglumic Acid—Abdominal pain—Methotrexate—testicular cancer	0.00103	0.00237	CcSEcCtD
Carglumic Acid—Body temperature increased—Methotrexate—testicular cancer	0.00103	0.00237	CcSEcCtD
Carglumic Acid—Somnolence—Doxorubicin—testicular cancer	0.00101	0.00231	CcSEcCtD
Carglumic Acid—Gastrointestinal pain—Epirubicin—testicular cancer	0.001	0.00229	CcSEcCtD
Carglumic Acid—Decreased appetite—Doxorubicin—testicular cancer	0.000984	0.00226	CcSEcCtD
Carglumic Acid—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000977	0.00224	CcSEcCtD
Carglumic Acid—Abdominal pain—Epirubicin—testicular cancer	0.000967	0.00222	CcSEcCtD
Carglumic Acid—Body temperature increased—Epirubicin—testicular cancer	0.000967	0.00222	CcSEcCtD
Carglumic Acid—Asthenia—Methotrexate—testicular cancer	0.000938	0.00215	CcSEcCtD
Carglumic Acid—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000926	0.00212	CcSEcCtD
Carglumic Acid—Body temperature increased—Doxorubicin—testicular cancer	0.000895	0.00205	CcSEcCtD
Carglumic Acid—Abdominal pain—Doxorubicin—testicular cancer	0.000895	0.00205	CcSEcCtD
Carglumic Acid—Diarrhoea—Methotrexate—testicular cancer	0.000895	0.00205	CcSEcCtD
Carglumic Acid—Asthenia—Epirubicin—testicular cancer	0.000878	0.00201	CcSEcCtD
Carglumic Acid—Diarrhoea—Epirubicin—testicular cancer	0.000837	0.00192	CcSEcCtD
Carglumic Acid—Vomiting—Methotrexate—testicular cancer	0.000831	0.00191	CcSEcCtD
Carglumic Acid—Rash—Methotrexate—testicular cancer	0.000824	0.00189	CcSEcCtD
Carglumic Acid—Dermatitis—Methotrexate—testicular cancer	0.000824	0.00189	CcSEcCtD
Carglumic Acid—Headache—Methotrexate—testicular cancer	0.000819	0.00188	CcSEcCtD
Carglumic Acid—Asthenia—Doxorubicin—testicular cancer	0.000812	0.00186	CcSEcCtD
Carglumic Acid—Vomiting—Epirubicin—testicular cancer	0.000778	0.00178	CcSEcCtD
Carglumic Acid—Diarrhoea—Doxorubicin—testicular cancer	0.000775	0.00178	CcSEcCtD
Carglumic Acid—Rash—Epirubicin—testicular cancer	0.000772	0.00177	CcSEcCtD
Carglumic Acid—Dermatitis—Epirubicin—testicular cancer	0.000771	0.00177	CcSEcCtD
Carglumic Acid—Headache—Epirubicin—testicular cancer	0.000767	0.00176	CcSEcCtD
Carglumic Acid—Vomiting—Doxorubicin—testicular cancer	0.00072	0.00165	CcSEcCtD
Carglumic Acid—Rash—Doxorubicin—testicular cancer	0.000714	0.00164	CcSEcCtD
Carglumic Acid—Dermatitis—Doxorubicin—testicular cancer	0.000713	0.00163	CcSEcCtD
Carglumic Acid—Headache—Doxorubicin—testicular cancer	0.000709	0.00163	CcSEcCtD
